Maplightrx
154 employees on LinkedIn · 1 known investors
MapLight is a biotech company developing therapeutics for central nervous system disorders, using a discovery platform that combines optogenetics, STARmap, and transcriptomics to identify and target specific brain circuits. Its pipeline addresses conditions including schizophrenia, Alzheimer's disease psychosis, autism spectrum disorder, and Parkinson's disease.
Investors · 1
Frequently asked questions
- What does Maplightrx do?
- MapLight is a biotech company developing therapeutics for central nervous system disorders, using a discovery platform that combines optogenetics, STARmap, and transcriptomics to identify and target specific brain circuits. Its pipeline addresses conditions including schizophrenia, Alzheimer's disease psychosis, autism spectrum disorder, and Parkinson's disease.
- Who are Maplightrx's investors?
- Maplightrx's investors include Avego BioScience Capital.